EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Lost in translation: Inconvenient truths on the utility of mouse models in Alzheimer’s disease research

Alberto Granzotto iD, Bryce Vissel, Stefano L Sensi

eLife · 27.09.2024 · 13

DOI: 10.7554/elife.90633 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift eLife, online erschienen am 27.09.2024. Verfasst von Alberto Granzotto und 2 weiteren Autor:innen. Beteiligte Einrichtung: Center for Advanced Studies and Technology - CAST, University G. d'Annunzio of Chieti-Pescara, Chieti, Italy. Hauptthemen laut MEDLINE: Alzheimer Disease, Disease Models, Animal. Die Arbeit wurde bisher 79-mal zitiert (Crossref) und nennt 170 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Horizon 2020 Framework Programme, European Union, Alzheimer's Association.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The recent, controversial approval of antibody-based treatments for Alzheimer’s disease (AD) is fueling a heated debate on the molecular determinants of this condition. The discussion should also incorporate a critical revision of the limitations of preclinical mouse models in advancing our understanding of AD. We critically discuss the limitations of animal models, stressing the need for careful consideration of how experiments are designed and results interpreted. We identify the shortcomings of AD models to recapitulate the complexity of the human disease. We dissect these issues at the quantitative, qualitative, temporal, and context-dependent levels. We argue that these models are based on the oversimplistic assumptions proposed by the amyloid cascade hypothesis (ACH) of AD and fail to account for the multifactorial nature of the condition. By shedding light on the constraints of current experimental tools, this review aims to foster the development and implementation of more clinically relevant tools. While we do not rule out a role for preclinical models, we call for alternative approaches to be explored and, most importantly, for a re-evaluation of the ACH.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseDisease Models, AnimalAnimalsMiceHumans

Stichwörter der Autor:innen

APOEAmyloidTauagingmedicineneurodegenerationneuroinflammationneuroscience

Autor:innen und Institutionen

  • Center for Advanced Studies and Technology - CAST, University G. d'Annunzio of Chieti-Pescara, Chieti, Italy.
  • Department of Neuroscience, Imaging, and Clinical Sciences, University G. d'Annunzio of Chieti-Pescara, Chieti, Italy.
  • St Vincent's Hospital Centre for Applied Medical Research, St Vincent's Hospital, Darlinghurst, Australia.
  • School of Clinical Medicine, UNSW Medicine & Health, St Vincent's Healthcare Clinical Campus, Faculty of Medicine and Health, UNSW Sydney, Sydney, Australia.
  • Institute for Advanced Biomedical Technologies - ITAB, University G. d'Annunzio of Chieti-Pescara, Chieti, Italy.
  • Institute of Neurology, SS Annunziata University Hospital, University G. d'Annunzio of Chieti-Pescara, Chieti, Italy.

ORCID-Profile: Alberto Granzotto

Förderung

  • Horizon 2020 Framework Programme
  • European Union
  • Alzheimer's Association
  • Italian Department of Health

Zitieren

APA

Granzotto, A., Vissel, B., & Sensi, S. L. (2024). Lost in translation: Inconvenient truths on the utility of mouse models in Alzheimer’s disease research. eLife, 13. https://doi.org/10.7554/elife.90633

Vancouver

Granzotto A, Vissel B, Sensi SL. Lost in translation: Inconvenient truths on the utility of mouse models in Alzheimer’s disease research. eLife. 2024;13. doi:10.7554/elife.90633

BibTeX
@article{Granzotto2024,
  author = {Granzotto, Alberto and Vissel, Bryce and Sensi, Stefano L},
  title = {Lost in translation: Inconvenient truths on the utility of mouse models in Alzheimer’s disease research},
  journal = {eLife},
  year = {2024},
  volume = {13},
  doi = {10.7554/elife.90633}
}
Kostenlos starten →